Transcutaneous sacral magnetic versus electrical stimulation for overactive bladder after spinal cord injury
Official title: The Effectiveness of Transcutaneous Sacral Neuromodulation Techniques-Magnetic Stimulation and Electrical Stimulation-on Detrusor Overactivity in Patients With Spinal Cord Injury
Run by Ankara City Hospital Bilkent · NCT07578532 · Data updated 2026-11-12
This trial will try two noninvasive sacral stimulation methods—magnetic and electrical—to see which better reduces bladder overactivity in adults (18–65) with suprasacral spinal cord injury who still have symptoms despite anticholinergic drugs.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Ankara City Hospital Bilkent Academic / other |
| Locations | 1 site (Ankara) |
| Status | Recruiting |
| Started | March 26, 2025 |
| Main results expected | September 26, 2026 |
| Study ends | September 26, 2026 |
| Registry record updated | May 11, 2026 |
| Trial ID | NCT07578532 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with traumatic or nontraumatic suprasacral spinal cord injury, urodynamically confirmed detrusor overactivity, and stable anticholinergic/sympathomimetic treatment for at least 3 months are ideal candidates.
✕Probably not a fit
Patients with cardiac pacemakers, epilepsy, metal implants near the treatment site, recent bladder botulinum toxin or neuromodulation within 6 months, prior neurogenic bladder surgery, or other neurological diseases affecting bladder function are excluded and unlikely to benefit from these interventions in this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized trial enrolling 40 adults with suprasacral spinal cord injury and urodynamically confirmed detrusor overactivity that is refractory to stable anticholinergic treatment. Participants are randomly assigned to receive either transcutaneous sacral magnetic stimulation (SMS) or transcutaneous sacral electrical stimulation (SES). Investigators will compare objective urodynamic measures (including maximum detrusor pressure during filling and bladder compliance), frequency of incontinence episodes, Neurogenic Bladder Dysfunction Score, and patient-reported discomfort/satisfaction. Safety and tolerability of both noninvasive stimulation approaches will also be recorded.
Why it matters
Potential benefit: If successful, one of these noninvasive stimulation methods could lower bladder pressures, reduce incontinence, and improve quality of life while avoiding or reducing reliance on medications or invasive procedures.
How similar studies have gone: Previous small studies and clinical experience with sacral electrical and magnetic stimulation show potential benefit for neurogenic detrusor overactivity, but direct randomized head-to-head comparisons are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-65 years old Traumatic and non-traumatic suprasacral SCI; Detrusor overactivity confirmed by urodynamics (spontaneous and/or provocative detrusor contraction during the filling phase will be accepted as detrusor overactivity) Patients who have been receiving anticholinergic and/or sympathomimetic treatment for the last 3 months and whose pharmacological medical treatment dose has not been changed since the last urodynamic examination will be included in the study. Exclusion Criteria: * Patients with a cardiac pacemaker, * Patients diagnosed with epilepsy, * Patients with a metal implant within a 10 cm radius of the area where the treatment will be applied, * Patients who have received botox injection to the bladder in the last 6 months, * Patients who have received any neuromodulation technique in the last 6 months, * Patients who have undergone surgical procedure for neurogenic bladder, * Patients with another neurological disease that may affect neurogenic bladder (Parkinson's, polyneuropathy, neurodegenerative disease, cerebrovascular disease, etc.) * Patients with acute urinary tract infection, * Patients diagnosed with bladder outlet obstruction (urethral stricture, benign prostatic hyperplasia, etc.) will not be included in the study.
Where it's running
-
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Zuhal Özişler — Ankara City Hospital Bilkent
- Study coordinator: Zeynep YAKISIR
- Email: zeynepyaksr@yahoo.com
- Phone: +905347278666
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rehabilitation data registry for spinal cord injury in Korea
This study tests whether long‑term disability and function after spinal cord injury can be predicted by combining medical and socioeconomic information gathered during and after inpatient rehabilitation.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Wireless implant for brain-computer interface in people with tetraplegia from spinal cord injury
This trial tests a wireless brain-computer interface implanted in adults with tetraplegia to see if it is safe and if it can help restore some function.
-
Able Kids device: safer gait aid for kids with neurologic gait problems
This study tests whether the ABLE Kids wearable exoskeleton can be safely used during a 10-session gait training program for children with neurological gait disorders or muscle weakness.
-
Dose optimization of acute intermittent hypoxia for improving leg strength after spinal cord injury
This study tests different short bursts of low-oxygen exposure to see which dose helps people with spinal cord injuries gain stronger leg muscles and faster reactions.
-
AI-guided prediction of blood pressure changes in spinal cord injury using perfusion index during a cool-temperature test
This study tests whether perfusion index can reliably predict changes in systolic blood pressure in people with spinal cord injury during a controlled cool temperature challenge.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.